+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Fully MagLev Left Ventricular Assist Device Market by Application (Bridge to Recovery, Bridge to Transplant, Destination Therapy), Distribution Channel (Direct Sales, Distributor Sales), Patient Age, Power Source, End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 183 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6125744
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The fully maglev left ventricular assist device represents a groundbreaking convergence of magnetic levitation technology and circulatory support solutions, offering clinicians and patients a transformative alternative to traditional blood pump systems. By employing a contactless rotor design, this generation of devices minimizes mechanical friction, reducing hemolysis and platelet activation while enhancing device durability. Such innovations not only elevate patient outcomes by decreasing the risk of thromboembolic complications but also extend service life beyond previous benchmarks, aligning with the evolving demands of long-term therapeutic strategies.

Against a backdrop of rising heart failure prevalence and constrained donor availability for transplantation, the advent of fully maglev left ventricular assist devices signifies a pivotal clinical advancement. As healthcare providers strive to balance patient quality of life with cost containment, the reliability and performance consistency of maglev-supported pumps form the foundation of next-generation circulatory assistance. With safety profiles strengthened through iterative design improvements, the stage is set for deeper exploration of market dynamics and strategic entry points in subsequent sections.

Tracing the Transformational Pivot Points and Market Inflection Milestones That Are Redefining the Fully MagLev Left Ventricular Assist Device Sector

Over the past decade, the landscape of left ventricular assist devices has been reshaped by a series of technological leaps and strategic partnerships. Initial mechanical bearing systems gave way to hybrid magnetic designs that mitigated wear, while the latest fully maglev iterations eliminate contact points altogether, redefining reliability standards. Concurrently, regulatory agencies have streamlined approval pathways for breakthrough medical technologies, enabling accelerated clinical adoption and facilitating cross-border technology transfers that enrich the global innovation ecosystem.

As industry stakeholders embrace precision engineering and digital integration, software-driven monitoring platforms now pair with maglev cores to deliver real-time hemodynamic analytics. These advanced connectivity solutions support remote tuning of pump parameters, enabling clinicians to preempt adverse events and personalize therapy trajectories. In this dynamic environment, collaborative research initiatives and value-based care models continue to unlock new avenues for device refinement and market expansion.

Assessing the Multilayered Consequences of 2025 US Tariff Adjustments on Supply Chains Innovation Incentives and Competitive Dynamics

The imposition of modified tariff schedules in the United States effective 2025 has introduced a complex overlay on global supply chains for advanced cardiovascular devices. Components sourced from key manufacturing hubs now face incremental duties, prompting procurement teams to reevaluate vendor portfolios and logistics frameworks. The resultant cost pressures are reshaping manufacturing footprints and encouraging localization of critical subassemblies to shield end-user pricing structures from volatile trade environments.

Meanwhile, the new tariff regime has accelerated negotiations on bilateral trade agreements and spurred industry associations to advocate for tariff exemptions on life-sustaining medical technologies. These efforts aim to preserve the momentum of innovation by safeguarding margins for research and development investments. As import duties shift, parallel strategies in tax planning and cross-border licensing agreements are emerging to mitigate financial impacts, reinforcing the resilience of the device ecosystem.

Uncovering Segmentation-Driven Pathways for Growth and Precision in Device Deployment Across Clinical and Business Verticals

Analyzing the market through the prism of clinical application reveals that use cases span bridge to recovery, bridge to transplant, and destination therapy, each carrying distinct performance and durability requirements. In direct sales models, original equipment manufacturers engage healthcare institutions with tailored training and service contracts, whereas distributor sales pathways leverage regional networks to optimize after-sales support and inventory turnover. Age demographics introduce another layer of complexity: adult patients often present different anatomical and lifestyle considerations compared to pediatric populations, driving design customizations and clinical protocols.

Power supply paradigms further differentiate device selection, with external battery configurations offering patient mobility and ambulatory freedom, while mains power solutions enhance in-hospital management and continuous operation. Finally, the interplay between cardiac centers and general hospitals as end users influences adoption rates, budgeting cycles, and deployment velocity. Examining these five segmentation dimensions together underscores the multifaceted strategies required to align product development, marketing, and service delivery with evolving stakeholder needs.

Mapping the Critical Regional Landscape and Unveiling Geographical Influences on Adoption Patterns and Healthcare Infrastructure Readiness

Across the Americas, infrastructure investments in tertiary cardiac care facilities and a growing network of specialized ventricular assist device centers have accelerated the adoption of fully maglev systems. Reimbursement policies continue to evolve, balancing cost-effectiveness assessments with the imperative to support next-generation technology deployment. Meanwhile, collaborative care networks are emerging to streamline referrals and optimize patient management throughout the continuum of heart failure treatment.

In Europe, the Middle East, and Africa, regulatory harmonization initiatives are paving the way for cross-regional market entry, while health authorities explore innovative funding models that share financial risk between payers and providers. Clinical trial hubs in select European countries are generating region-specific evidence to guide reimbursement decisions. In Asia-Pacific, surging prevalence of cardiovascular disease and rapid modernization of healthcare infrastructures have created fertile grounds for technology transfer. Strategic partnerships between local distributors and global manufacturers are driving targeted educational programs to build clinician expertise and patient awareness.

Analyzing Competitive Footprints and Strategic Innovations from Leading Players in the Fully MagLev Left Ventricular Assist Device Arena

Leading players in the fully maglev left ventricular assist device arena have leveraged cross-disciplinary expertise to refine pump architectures and digital health integration. Their strategic roadmaps emphasize modular designs that can be rapidly upgraded as magnetic bearing materials and sensor capabilities advance. Collaborative research agreements with academic medical centers underpin iterative clinical studies that validate safety and efficacy across diverse patient cohorts.

Competitive differentiation has emerged through service excellence, with remote monitoring platforms offering predictive maintenance alerts and software upgrades delivered over secure networks. Manufacturers are also exploring flexible financing arrangements and outcome-based reimbursement schemes to align stakeholder interests. As new entrants seek to claim a foothold, patent landscapes and intellectual property portfolios will continue to shape the contours of competitive rivalry.

Developing Proactive Strategic Imperatives and Tactical Roadmaps to Navigate Technological Advancements and Market Shifts in Cardiovascular Support

Industry leaders should prioritize robust post-market surveillance systems that capture real-world data on device performance, optimizing clinical protocols and supporting continuous product improvement. Cultivating close collaborations with regulatory bodies and key opinion leaders will streamline approval processes for next-generation iterations and foster early adoption in flagship healthcare institutions. Furthermore, establishing co-development partnerships with digital health firms can enhance remote patient management and differentiate service offerings.

To navigate evolving trade landscapes, organizations must develop agile supply chain models that incorporate dual sourcing for critical components and flexible assembly locations. Embedding scenario planning into strategic roadmaps will enable proactive responses to tariff fluctuations and geopolitical shifts. By aligning commercial and clinical insights with financial risk-sharing structures, companies can accelerate market penetration while ensuring long-term sustainability.

Detailing Rigorous Research Protocols and Analytical Frameworks Underpinning Comprehensive Insights into the Fully MagLev Left Ventricular Assist Device Study

This research is grounded in a rigorous framework combining primary and secondary methodologies. In-depth interviews with cardiac surgeons, biomedical engineers, and procurement specialists provided qualitative insights into clinical adoption barriers and value perceptions. Simultaneously, patent analysis and review of regulatory filings elucidated technological trajectories and compliance benchmarks across key markets.

Secondary sources-including peer-reviewed journals, government publications, and industry white papers-supplied quantitative data on epidemiology, healthcare infrastructure, and reimbursement landscapes. Analytical models were constructed to triangulate findings, with sensitivity analyses ensuring robustness against data variability. All insights underwent validation through expert panels to maintain objectivity and relevance for decision-makers.

Summarizing Key Takeaways and Strategic Implications to Solidify Understanding and Propel Future Engagements with MagLev Left Ventricular Assist Devices

This executive summary has illuminated the multifaceted landscape of fully maglev left ventricular assist devices, from breakthrough magnetic bearing innovations to the strategic implications of shifting tariff regimes. We have also dissected critical segmentation drivers and regional dynamics that will shape adoption patterns and competitive positioning in the coming years.

By integrating clinical, commercial, and regulatory perspectives, stakeholders can forge informed strategies that harness the full potential of maglev-enabled circulatory support. Moving forward, maintaining agility in product development, supply chain design, and stakeholder engagement will be essential to capitalize on emerging opportunities and deliver meaningful patient outcomes.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Application
    • Bridge To Recovery
    • Bridge To Transplant
    • Destination Therapy
  • Distribution Channel
    • Direct Sales
    • Distributor Sales
  • Patient Age
    • Adult
    • Pediatric
  • Power Source
    • External Battery
    • Mains Power
  • End User
    • Cardiac Centers
    • Hospitals
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report delves into recent significant developments and analyzes trends in each of the following companies:
  • Abbott Laboratories
  • Medtronic plc
  • Berlin Heart GmbH
  • SynCardia Systems, LLC
  • Jarvik Heart, Inc.
  • BiVACOR, Inc.
  • CH Biomedical (Suzhou) Co., Ltd
  • Leviticus Cardio, LLC
  • CorWave SA
  • Teleflex Incorporated

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Integration of AI-driven predictive analytics platforms for maglev LVAD performance monitoring and patient management
5.2. Development of wireless energy transfer systems to enable fully implantable maglev LVADs without external driveline
5.3. Advancements in hemocompatible surface coatings to reduce thrombosis in magnetic levitation ventricular assist devices
5.4. Clinical trial outcomes demonstrating improved long-term patient survival with next-generation maglev LVAD technologies
5.5. Adoption of home-based remote monitoring solutions for continuous tracking of fully maglev LVAD patient parameters
5.6. Regulatory approval pathways evolving to accelerate market entry for innovative magnetic levitation ventricular assist devices
5.7. Strategic partnerships between device manufacturers and telehealth providers to enhance post-implant care coordination for maglev LVAD patients
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Fully MagLev Left Ventricular Assist Device Market, by Application
8.1. Introduction
8.2. Bridge to Recovery
8.3. Bridge to Transplant
8.4. Destination Therapy
9. Fully MagLev Left Ventricular Assist Device Market, by Distribution Channel
9.1. Introduction
9.2. Direct Sales
9.3. Distributor Sales
10. Fully MagLev Left Ventricular Assist Device Market, by Patient Age
10.1. Introduction
10.2. Adult
10.3. Pediatric
11. Fully MagLev Left Ventricular Assist Device Market, by Power Source
11.1. Introduction
11.2. External Battery
11.3. Mains Power
12. Fully MagLev Left Ventricular Assist Device Market, by End User
12.1. Introduction
12.2. Cardiac Centers
12.3. Hospitals
13. Americas Fully MagLev Left Ventricular Assist Device Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Fully MagLev Left Ventricular Assist Device Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Fully MagLev Left Ventricular Assist Device Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Abbott Laboratories
16.3.2. Medtronic plc
16.3.3. Berlin Heart GmbH
16.3.4. SynCardia Systems, LLC
16.3.5. Jarvik Heart, Inc.
16.3.6. BiVACOR, Inc.
16.3.7. CH Biomedical (Suzhou) Co., Ltd
16.3.8. Leviticus Cardio, LLC
16.3.9. CorWave SA
16.3.10. Teleflex Incorporated
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 6. GLOBAL FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 8. GLOBAL FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PATIENT AGE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PATIENT AGE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY POWER SOURCE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY POWER SOURCE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET: RESEARCHAI
FIGURE 26. FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET: RESEARCHSTATISTICS
FIGURE 27. FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET: RESEARCHCONTACTS
FIGURE 28. FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY BRIDGE TO RECOVERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY BRIDGE TO RECOVERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY BRIDGE TO TRANSPLANT, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY BRIDGE TO TRANSPLANT, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DESTINATION THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DESTINATION THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DISTRIBUTOR SALES, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DISTRIBUTOR SALES, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PATIENT AGE, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PATIENT AGE, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY ADULT, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY ADULT, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PEDIATRIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY POWER SOURCE, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY POWER SOURCE, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY EXTERNAL BATTERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY EXTERNAL BATTERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY MAINS POWER, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY MAINS POWER, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY CARDIAC CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY CARDIAC CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. AMERICAS FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 42. AMERICAS FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 43. AMERICAS FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 44. AMERICAS FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 45. AMERICAS FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PATIENT AGE, 2018-2024 (USD MILLION)
TABLE 46. AMERICAS FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PATIENT AGE, 2025-2030 (USD MILLION)
TABLE 47. AMERICAS FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY POWER SOURCE, 2018-2024 (USD MILLION)
TABLE 48. AMERICAS FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY POWER SOURCE, 2025-2030 (USD MILLION)
TABLE 49. AMERICAS FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 50. AMERICAS FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 51. AMERICAS FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 52. AMERICAS FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 53. UNITED STATES FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 54. UNITED STATES FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 55. UNITED STATES FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 56. UNITED STATES FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 57. UNITED STATES FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PATIENT AGE, 2018-2024 (USD MILLION)
TABLE 58. UNITED STATES FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PATIENT AGE, 2025-2030 (USD MILLION)
TABLE 59. UNITED STATES FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY POWER SOURCE, 2018-2024 (USD MILLION)
TABLE 60. UNITED STATES FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY POWER SOURCE, 2025-2030 (USD MILLION)
TABLE 61. UNITED STATES FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 62. UNITED STATES FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 63. UNITED STATES FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 64. UNITED STATES FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 65. CANADA FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 66. CANADA FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 67. CANADA FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 68. CANADA FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 69. CANADA FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PATIENT AGE, 2018-2024 (USD MILLION)
TABLE 70. CANADA FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PATIENT AGE, 2025-2030 (USD MILLION)
TABLE 71. CANADA FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY POWER SOURCE, 2018-2024 (USD MILLION)
TABLE 72. CANADA FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY POWER SOURCE, 2025-2030 (USD MILLION)
TABLE 73. CANADA FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 74. CANADA FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 75. MEXICO FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 76. MEXICO FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 77. MEXICO FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 78. MEXICO FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 79. MEXICO FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PATIENT AGE, 2018-2024 (USD MILLION)
TABLE 80. MEXICO FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PATIENT AGE, 2025-2030 (USD MILLION)
TABLE 81. MEXICO FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY POWER SOURCE, 2018-2024 (USD MILLION)
TABLE 82. MEXICO FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY POWER SOURCE, 2025-2030 (USD MILLION)
TABLE 83. MEXICO FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 84. MEXICO FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 85. BRAZIL FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 86. BRAZIL FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 87. BRAZIL FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 88. BRAZIL FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 89. BRAZIL FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PATIENT AGE, 2018-2024 (USD MILLION)
TABLE 90. BRAZIL FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PATIENT AGE, 2025-2030 (USD MILLION)
TABLE 91. BRAZIL FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY POWER SOURCE, 2018-2024 (USD MILLION)
TABLE 92. BRAZIL FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY POWER SOURCE, 2025-2030 (USD MILLION)
TABLE 93. BRAZIL FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 94. BRAZIL FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 95. ARGENTINA FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 96. ARGENTINA FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 97. ARGENTINA FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 98. ARGENTINA FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 99. ARGENTINA FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PATIENT AGE, 2018-2024 (USD MILLION)
TABLE 100. ARGENTINA FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PATIENT AGE, 2025-2030 (USD MILLION)
TABLE 101. ARGENTINA FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY POWER SOURCE, 2018-2024 (USD MILLION)
TABLE 102. ARGENTINA FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY POWER SOURCE, 2025-2030 (USD MILLION)
TABLE 103. ARGENTINA FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 104. ARGENTINA FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 107. EUROPE, MIDDLE EAST & AFRICA FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 108. EUROPE, MIDDLE EAST & AFRICA FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 109. EUROPE, MIDDLE EAST & AFRICA FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PATIENT AGE, 2018-2024 (USD MILLION)
TABLE 110. EUROPE, MIDDLE EAST & AFRICA FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PATIENT AGE, 2025-2030 (USD MILLION)
TABLE 111. EUROPE, MIDDLE EAST & AFRICA FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY POWER SOURCE, 2018-2024 (USD MILLION)
TABLE 112. EUROPE, MIDDLE EAST & AFRICA FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY POWER SOURCE, 2025-2030 (USD MILLION)
TABLE 113. EUROPE, MIDDLE EAST & AFRICA FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 114. EUROPE, MIDDLE EAST & AFRICA FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 115. EUROPE, MIDDLE EAST & AFRICA FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 116. EUROPE, MIDDLE EAST & AFRICA FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 117. UNITED KINGDOM FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 118. UNITED KINGDOM FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 119. UNITED KINGDOM FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 120. UNITED KINGDOM FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 121. UNITED KINGDOM FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PATIENT AGE, 2018-2024 (USD MILLION)
TABLE 122. UNITED KINGDOM FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PATIENT AGE, 2025-2030 (USD MILLION)
TABLE 123. UNITED KINGDOM FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY POWER SOURCE, 2018-2024 (USD MILLION)
TABLE 124. UNITED KINGDOM FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY POWER SOURCE, 2025-2030 (USD MILLION)
TABLE 125. UNITED KINGDOM FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 126. UNITED KINGDOM FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 127. GERMANY FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 128. GERMANY FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 129. GERMANY FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 130. GERMANY FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 131. GERMANY FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PATIENT AGE, 2018-2024 (USD MILLION)
TABLE 132. GERMANY FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PATIENT AGE, 2025-2030 (USD MILLION)
TABLE 133. GERMANY FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY POWER SOURCE, 2018-2024 (USD MILLION)
TABLE 134. GERMANY FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY POWER SOURCE, 2025-2030 (USD MILLION)
TABLE 135. GERMANY FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 136. GERMANY FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 137. FRANCE FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 138. FRANCE FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 139. FRANCE FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 140. FRANCE FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 141. FRANCE FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PATIENT AGE, 2018-2024 (USD MILLION)
TABLE 142. FRANCE FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PATIENT AGE, 2025-2030 (USD MILLION)
TABLE 143. FRANCE FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY POWER SOURCE, 2018-2024 (USD MILLION)
TABLE 144. FRANCE FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY POWER SOURCE, 2025-2030 (USD MILLION)
TABLE 145. FRANCE FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 146. FRANCE FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 147. RUSSIA FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 148. RUSSIA FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 149. RUSSIA FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 150. RUSSIA FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 151. RUSSIA FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PATIENT AGE, 2018-2024 (USD MILLION)
TABLE 152. RUSSIA FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PATIENT AGE, 2025-2030 (USD MILLION)
TABLE 153. RUSSIA FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY POWER SOURCE, 2018-2024 (USD MILLION)
TABLE 154. RUSSIA FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY POWER SOURCE, 2025-2030 (USD MILLION)
TABLE 155. RUSSIA FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 156. RUSSIA FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 157. ITALY FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 158. ITALY FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 159. ITALY FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 160. ITALY FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 161. ITALY FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PATIENT AGE, 2018-2024 (USD MILLION)
TABLE 162. ITALY FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PATIENT AGE, 2025-2030 (USD MILLION)
TABLE 163. ITALY FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY POWER SOURCE, 2018-2024 (USD MILLION)
TABLE 164. ITALY FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY POWER SOURCE, 2025-2030 (USD MILLION)
TABLE 165. ITALY FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 166. ITALY FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 167. SPAIN FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 168. SPAIN FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 169. SPAIN FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 170. SPAIN FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 171. SPAIN FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PATIENT AGE, 2018-2024 (USD MILLION)
TABLE 172. SPAIN FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PATIENT AGE, 2025-2030 (USD MILLION)
TABLE 173. SPAIN FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY POWER SOURCE, 2018-2024 (USD MILLION)
TABLE 174. SPAIN FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY POWER SOURCE, 2025-2030 (USD MILLION)
TABLE 175. SPAIN FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 176. SPAIN FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 177. UNITED ARAB EMIRATES FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 178. UNITED ARAB EMIRATES FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 179. UNITED ARAB EMIRATES FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 180. UNITED ARAB EMIRATES FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 181. UNITED ARAB EMIRATES FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PATIENT AGE, 2018-2024 (USD MILLION)
TABLE 182. UNITED ARAB EMIRATES FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PATIENT AGE, 2025-2030 (USD MILLION)
TABLE 183. UNITED ARAB EMIRATES FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY POWER SOURCE, 2018-2024 (USD MILLION)
TABLE 184. UNITED ARAB EMIRATES FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY POWER SOURCE, 2025-2030 (USD MILLION)
TABLE 185. UNITED ARAB EMIRATES FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 186. UNITED ARAB EMIRATES FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 187. SAUDI ARABIA FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 188. SAUDI ARABIA FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 189. SAUDI ARABIA FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 190. SAUDI ARABIA FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 191. SAUDI ARABIA FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PATIENT AGE, 2018-2024 (USD MILLION)
TABLE 192. SAUDI ARABIA FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PATIENT AGE, 2025-2030 (USD MILLION)
TABLE 193. SAUDI ARABIA FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY POWER SOURCE, 2018-2024 (USD MILLION)
TABLE 194. SAUDI ARABIA FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY POWER SOURCE, 2025-2030 (USD MILLION)
TABLE 195. SAUDI ARABIA FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 196. SAUDI ARABIA FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 197. SOUTH AFRICA FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 198. SOUTH AFRICA FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 199. SOUTH AFRICA FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 200. SOUTH AFRICA FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 201. SOUTH AFRICA FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PATIENT AGE, 2018-2024 (USD MILLION)
TABLE 202. SOUTH AFRICA FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PATIENT AGE, 2025-2030 (USD MILLION)
TABLE 203. SOUTH AFRICA FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY POWER SOURCE, 2018-2024 (USD MILLION)
TABLE 204. SOUTH AFRICA FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY POWER SOURCE, 2025-2030 (USD MILLION)
TABLE 205. SOUTH AFRICA FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 206. SOUTH AFRICA FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 207. DENMARK FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 208. DENMARK FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 209. DENMARK FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 210. DENMARK FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 211. DENMARK FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PATIENT AGE, 2018-2024 (USD MILLION)
TABLE 212. DENMARK FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PATIENT AGE, 2025-2030 (USD MILLION)
TABLE 213. DENMARK FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY POWER SOURCE, 2018-2024 (USD MILLION)
TABLE 214. DENMARK FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY POWER SOURCE, 2025-2030 (USD MILLION)
TABLE 215. DENMARK FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 216. DENMARK FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 217. NETHERLANDS FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 218. NETHERLANDS FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 219. NETHERLANDS FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 220. NETHERLANDS FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 221. NETHERLANDS FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PATIENT AGE, 2018-2024 (USD MILLION)
TABLE 222. NETHERLANDS FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PATIENT AGE, 2025-2030 (USD MILLION)
TABLE 223. NETHERLANDS FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY POWER SOURCE, 2018-2024 (USD MILLION)
TABLE 224. NETHERLANDS FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY POWER SOURCE, 2025-2030 (USD MILLION)
TABLE 225. NETHERLANDS FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 226. NETHERLANDS FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 227. QATAR FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 228. QATAR FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 229. QATAR FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 230. QATAR FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 231. QATAR FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PATIENT AGE, 2018-2024 (USD MILLION)
TABLE 232. QATAR FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PATIENT AGE, 2025-2030 (USD MILLION)
TABLE 233. QATAR FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY POWER SOURCE, 2018-2024 (USD MILLION)
TABLE 234. QATAR FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY POWER SOURCE, 2025-2030 (USD MILLION)
TABLE 235. QATAR FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 236. QATAR FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 237. FINLAND FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 238. FINLAND FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 239. FINLAND FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 240. FINLAND FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 241. FINLAND FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PATIENT AGE, 2018-2024 (USD MILLION)
TABLE 242. FINLAND FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PATIENT AGE, 2025-2030 (USD MILLION)
TABLE 243. FINLAND FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY POWER SOURCE, 2018-2024 (USD MILLION)
TABLE 244. FINLAND FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY POWER SOURCE, 2025-2030 (USD MILLION)
TABLE 245. FINLAND FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 246. FINLAND FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 247. SWEDEN FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 248. SWEDEN FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 249. SWEDEN FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 250. SWEDEN FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 251. SWEDEN FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PATIENT AGE, 2018-2024 (USD MILLION)
TABLE 252. SWEDEN FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PATIENT AGE, 2025-2030 (USD MILLION)
TABLE 253. SWEDEN FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY POWER SOURCE, 2018-2024 (USD MILLION)
TABLE 254. SWEDEN FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY POWER SOURCE, 2025-2030 (USD MILLION)
TABLE 255. SWEDEN FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 256. SWEDEN FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 257. NIGERIA FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 258. NIGERIA FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 259. NIGERIA FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 260. NIGERIA FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 261. NIGERIA FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PATIENT AGE, 2018-2024 (USD MILLION)
TABLE 262. NIGERIA FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PATIENT AGE, 2025-2030 (USD MILLION)
TABLE 263. NIGERIA FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY POWER SOURCE, 2018-2024 (USD MILLION)
TABLE 264. NIGERIA FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY POWER SOURCE, 2025-2030 (USD MILLION)
TABLE 265. NIGERIA FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 266. NIGERIA FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 267. EGYPT FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 268. EGYPT FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 269. EGYPT FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 270. EGYPT FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 271. EGYPT FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PATIENT AGE, 2018-2024 (USD MILLION)
TABLE 272. EGYPT FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PATIENT AGE, 2025-2030 (USD MILLION)
TABLE 273. EGYPT FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY POWER SOURCE, 2018-2024 (USD MILLION)
TABLE 274. EGYPT FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY POWER SOURCE, 2025-2030 (USD MILLION)
TABLE 275. EGYPT FULLY MAGLEV LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY END USER, 201

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Fully MagLev Left Ventricular Assist Device market report include:
  • Abbott Laboratories
  • Medtronic plc
  • Berlin Heart GmbH
  • SynCardia Systems, LLC
  • Jarvik Heart, Inc.
  • BiVACOR, Inc.
  • CH Biomedical (Suzhou) Co., Ltd
  • Leviticus Cardio, LLC
  • CorWave SA
  • Teleflex Incorporated